Global CA Tumor Markers Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

This report presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.



I. Introduction
II. CA TUMOR MARKERS Worldwide Market and Technology Overview
A. CA Tumor Markers: Clinical Significance
and Laboratory Practices
1. CA 15-3/27.29
2. CA 19-9
3. CA 125
B. Instrumentation Review And
Market Needs
1. Abbott AxSYM
2. Abbott Architect c4000
3. Abbott Architect i2000 Series
4. Abbott Architect ci8200 System
5. Beckman Coulter UniCel Series
6. Beckman Coulter Access
7. Binding Site ESP600
8. bioMerieux Mini Vidas
9. Carolina Chemistries BioLis 24i
10. DiaSorin Liaison
11. Horiba ABX Pentra 400
12. Inverness DS2
13. J&J Vitros ECi/ECiQ
14. J&J Vitros 3600
15. J&J Vitros 5600
16. Olympus AU5400
17. Olympus AU3000i
18. Olympus AU2700
19. Roche Modular Analytics
20. Roche Cobas Integra 400
21. Roche Cobas Integra 400 Plus
22. Roche Elecsys
23. Roche Cobas c311
24. Siemens ADVIA Centaur
25. Siemens Dimension
26. Siemens Dimension RxL Max

27. Siemens Dimension Vista 500
28. Siemens Immulite
29. Siemens Stratus
30. Tosoh AIA-Series
31. Vital Diagnostics ATAC 8000
32. Vital Diagnostics Envoy 500
C. Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Radioimmunoassay (RIA)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
d. Fluorescent Immunoassays
e. Luminescence
- Chemiluminescence
- Bioluminescence
f. Latex Agglutination
g. Immunoprecipitation
H. Affinity Chromatographu
e. Liposome Flow-Injection Immunoassay
3. Molecular Diagnostics
a. Technology Overview
b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others

4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas
Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
a. CT
b. MRI
c. NMR
d. PET
e. Photonics Spectroscopy
E. Personal Testing
III. France: Market Size, Growth and Major Suppliers
Sales and Market Shares
IV. Germany: Market Size, Growth and Major Suppliers
Sales and Market Shares
V. Italy: Test Volume and Diagnostics Sales Forecast
by Market Segment

VI. Japan: Market Size, Growth and Major Suppliers
Sales and Market Shares
VII. Spain: Market Size, Growth and Major Suppliers
Sales and Market Shares
VIII. U.K.: Test Volume and Diagnostics Sales Forecast
by Market Segment
IX. U.S.A.: Market Size, Growth and Major Suppliers
Sales and Market Shares

X. Design Criteria for Decentralized Testing Products
XI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
XII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. Competitive Profiles
- Abbott
- AdnaGen
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- Cepheid
- Correlogic Systems

- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Hologic/Gen-Probe
- Guided Therapeutics
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila
CA TUMOR MARKERS: US, EUROPE, JAPAN
Test Volume, Sales Forecasts and Supplier Shares by Country

List Of Tables


Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
France
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
France
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
France
CA 125 Test Volume and Diagnostics Sales
by Market Segment
France
CA 15-3/27.29 Testing Market by Major Supplier
France
CA 19-9 Testing Market by Major Supplier
France
CA 125 Testing Market by Major Supplier
Germany
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment


Germany
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 15-3/27.29 Testing Market by Major Supplier
Germany
CA 19-9 Testing Market by Major Supplier
Germany
CA 125 Testing Market by Major Supplier
Italy
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Italy
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Italy
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 15-3/27.29 Testing Market by Major Supplier


Japan
CA 19-9 Testing Market by Major Supplier
Japan
CA 125 Testing Market by Major Supplier
Spain
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 15-3/27.29 Testing Market by Major Supplier
Spain
CA 19-9 Testing Market by Major Supplier
Spain
CA 125 Testing Market by Major Supplier
U.K.
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
U.K.
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
U.K.
CA 125 Test Volume and Diagnostics Sales
by Market Segment

U.S.A.
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 125 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 15-3/27.29 Testing Market by Major Supplier
U.S.A.
CA 19-9 Testing Market by Major Supplier
U.S.A.
CA 125 Testing Market by Major Supplier

2020 Global Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Americas, EMEA, APAC--A 68-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

This new 68-country report is available by region, country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and

USD 45000 View Report

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027

Global Estrogen Replacement Therapy Market by Dosage Forms (Patches, Tablets, Gels/Creams, Suppositories, Implants And Injections), By Routes Of Administration (Oral, Topical, Subcutaneous Pellets, Injections, and Others), By End-User (Hospitals, Clinics, Pharmacy Store, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa), Forecast from 2020 to 2027 market research report available in single user pdf license with Aarkstore Enterprise at USD 4950

USD 4950 View Report

Global Cardiac Output Monitoring Devices Market Research Report 2020-2024

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Cardiac Output Monitoring Devices Report by Material, Application,

USD 2850 View Report

2020 Global Campylobacter Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition,

USD 3850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available